Antidepressive Agents, Tricyclic

• 

  Subject Areas on Research

  • "Fibrositis" syndrome. 
  • A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. 
  • A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. 
  • A pilot study of mirtazapine in post-traumatic stress disorder. 
  • A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. 
  • Adding a tricyclic antidepressant to a monoamine oxidase inhibitor. 
  • An overview of the management of post-vasectomy pain syndrome. 
  • Antidepressant therapy in patients with ischemic heart disease. 
  • Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. 
  • Antidepressant use in elderly medical inpatients: lessons from an attempted clinical trial. 
  • Antidepressant use in pregnancy and the risk of cardiac defects. 
  • Antidepressant use, depression, and survival in patients with heart failure. 
  • Anxiety, depression, and heart rate variability. 
  • Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. 
  • Clinical trial evidence for treatment of depression in heart failure. 
  • Clomipramine and glucocorticoid receptor function. 
  • Concepts in pain management. 
  • Consensus statement on depression, anxiety, and cardiovascular disease. 
  • Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. 
  • Depressive pseudodementia: a suggested diagnostic profile. 
  • Detection and treatment of major depression in older medically ill hospitalized patients. 
  • Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. 
  • Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients. 
  • Dynamic systems theory as a paradigm for the study of change in psychotherapy: an application to cognitive therapy for depression. 
  • Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. 
  • Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia. 
  • Efficacy of milnacipran in patients with fibromyalgia. 
  • Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania. 
  • Forms of atypical depression and their response to antidepressant drugs. 
  • Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. 
  • Identifying depression in the first postpartum year: guidelines for office-based screening and referral. 
  • Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. 
  • Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. 
  • Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. 
  • Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. 
  • Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. 
  • Paroxetine in the treatment of generalised anxiety disorder. 
  • Pharmacotherapy of generalized anxiety disorder. 
  • Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. 
  • Postpartum depression: a randomized trial of sertraline versus nortriptyline. 
  • Potentiated opioid analgesia in norepinephrine transporter knock-out mice. 
  • Prediction and decision making using Bayesian hierarchical models. 
  • Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. 
  • Prevention of recurrent postpartum depression: a randomized clinical trial. 
  • Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. 
  • Psychopharmacologic treatment of children and adolescents with anxiety disorders. 
  • Review of the use of mirtazapine in the treatment of depression. 
  • Sensory neuromodulators in functional nausea and vomiting: predictors of response. 
  • Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. 
  • Should physicians screen for depression in elderly medical inpatients?: Results of a decision analysis. 
  • The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. 
  • The long-term treatment of panic disorder. 
  • The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. 
  • Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata. 
  • Treatment considerations for patients with neuropathic pain and other medical comorbidities. 
  • Tricyclic antidepressant prescribing for nonpsychiatric disorders. An analysis based on data from the 1985 National Ambulatory Medical Care Survey. 
  • Tricyclic antidepressants. 
  • Tricyclic-induced akathisia in patients taking conjugated estrogens. 
  • Untreated depression and hippocampal volume loss. 
  • Vintage treatments for PTSD: a reconsideration of tricyclic drugs. 
  • Weight changes in postpartum women with remitted depression. 
• 

  Keywords of People

  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology